BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 30193823)

  • 1. Lower expression of plasma-derived exosome miR-21 levels in HIV-1 elite controllers with decreasing CD4 T cell count.
    Ruiz-de-León MJ; Jiménez-Sousa MA; Moreno S; García M; Gutiérrez-Rivas M; León A; Montero-Alonso M; González-García J; Resino S; Rallón N; Benito JM; Vallejo A;
    J Microbiol Immunol Infect; 2019 Aug; 52(4):667-671. PubMed ID: 30193823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs differentially present in the plasma of HIV elite controllers reduce HIV infection in vitro.
    Reynoso R; Laufer N; Hackl M; Skalicky S; Monteforte R; Turk G; Carobene M; Quarleri J; Cahn P; Werner R; Stoiber H; Grillari-Voglauer R; Grillari J
    Sci Rep; 2014 Aug; 4():5915. PubMed ID: 25081906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated Abundance, Size, and MicroRNA Content of Plasma Extracellular Vesicles in Viremic HIV-1+ Patients: Correlations With Known Markers of Disease Progression.
    Hubert A; Subra C; Jenabian MA; Tremblay Labrecque PF; Tremblay C; Laffont B; Provost P; Routy JP; Gilbert C
    J Acquir Immune Defic Syndr; 2015 Nov; 70(3):219-27. PubMed ID: 26181817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy.
    Hunt PW; Brenchley J; Sinclair E; McCune JM; Roland M; Page-Shafer K; Hsue P; Emu B; Krone M; Lampiris H; Douek D; Martin JN; Deeks SG
    J Infect Dis; 2008 Jan; 197(1):126-33. PubMed ID: 18171295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune activation and antibody responses in non-progressing elite controller individuals infected with HIV-1.
    Bello G; Velasco-de-Castro CA; Bongertz V; Rodrigues CA; Giacoia-Gripp CB; Pilotto JH; Grinsztejn B; Veloso VG; Morgado MG
    J Med Virol; 2009 Oct; 81(10):1681-90. PubMed ID: 19697415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased soluble Fas in HIV-infected hemophilia patients with CD4+ and CD8+ cell count increases and viral load and immune complex decreases.
    Daniel V; Süsal C; Weimer R; Zimmermann R; Huth-Kühne A; Opelz G
    AIDS Res Hum Retroviruses; 2001 Mar; 17(4):329-35. PubMed ID: 11242519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Levels of Macrophage Inflammatory Proteins Result in Resistance to R5-Tropic HIV-1 in a Subset of Elite Controllers.
    Walker WE; Kurscheid S; Joshi S; Lopez CA; Goh G; Choi M; Barakat L; Francis J; Fisher A; Kozal M; Zapata H; Shaw A; Lifton R; Sutton RE; Fikrig E
    J Virol; 2015 May; 89(10):5502-14. PubMed ID: 25740989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blimp-1 overexpression is associated with low HIV-1 reservoir and transcription levels in central memory CD4+ T cells from elite controllers.
    de Masson A; Kirilovsky A; Zoorob R; Avettand-Fenoel V; Morin V; Oudin A; Descours B; Rouzioux C; Autran B
    AIDS; 2014 Jul; 28(11):1567-77. PubMed ID: 24804861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal T-cell activation in elite controllers with preserved CD4+ T-cell counts.
    Bansal A; Sterrett S; Erdmann N; Westfall AO; Dionne-Odom J; Overton ET; Goepfert PA
    AIDS; 2015 Nov; 29(17):2245-54. PubMed ID: 26544698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
    Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
    Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4 T cell count reconstitution in HIV controllers after highly active antiretroviral therapy.
    Okulicz JF; Grandits GA; Weintrob AC; Landrum ML; Ganesan A; Crum-Cianflone NF; Agan BK; Marconi VC
    Clin Infect Dis; 2010 Apr; 50(8):1187-91. PubMed ID: 20218878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyfunctional CD4(+) T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine.
    Van Braeckel E; Desombere I; Clement F; Vandekerckhove L; Verhofstede C; Vogelaers D; Leroux-Roels G
    Vaccine; 2013 Aug; 31(36):3739-46. PubMed ID: 23707169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study.
    Murray DD; Suzuki K; Law M; Trebicka J; Neuhaus J; Wentworth D; Johnson M; Vjecha MJ; Kelleher AD; Emery S;
    PLoS One; 2015; 10(10):e0139981. PubMed ID: 26465293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV elite control is associated with reduced TRAILshort expression.
    Paim AC; Cummins NW; Natesampillai S; Garcia-Rivera E; Kogan N; Neogi U; Sönnerborg A; Sperk M; Bren GD; Deeks S; Polley E; Badley AD
    AIDS; 2019 Sep; 33(11):1757-1763. PubMed ID: 31149947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential miRNA plasma profiles associated with the spontaneous loss of HIV-1 control: miR-199a-3p and its potential role as a biomarker for quick screening of elite controllers.
    Masip J; Gasca-Capote C; Jimenez-Leon MR; Peraire J; Perez-Gomez A; Alba V; Malo AI; Leal L; Martín CR; Rallón N; Viladés C; Olona M; Vidal F; Ruiz-Mateos E; Rull A;
    Clin Transl Med; 2021 Jul; 11(7):e474. PubMed ID: 34323411
    [No Abstract]   [Full Text] [Related]  

  • 16. MicroRNA-29 family expression and its relation to antiviral immune response and viro-immunological markers in HIV-1-infected patients.
    Monteleone K; Selvaggi C; Cacciotti G; Falasca F; Mezzaroma I; D'Ettorre G; Turriziani O; Vullo V; Antonelli G; Scagnolari C
    BMC Infect Dis; 2015 Feb; 15():51. PubMed ID: 25808800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated IP10 levels are associated with immune activation and low CD4⁺ T-cell counts in HIV controller patients.
    Noel N; Boufassa F; Lécuroux C; Saez-Cirion A; Bourgeois C; Dunyach-Remy C; Goujard C; Rouzioux C; Meyer L; Pancino G; Venet A; Lambotte O;
    AIDS; 2014 Feb; 28(4):467-76. PubMed ID: 24378753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case report: mechanisms of HIV elite control in two African women.
    Moosa Y; Tanko RF; Ramsuran V; Singh R; Madzivhandila M; Yende-Zuma N; Abrahams MR; Selhorst P; Gounder K; Moore PL; Williamson C; Abdool Karim SS; Garrett NJ; Burgers WA
    BMC Infect Dis; 2018 Jan; 18(1):54. PubMed ID: 29370775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of HIV-1 Pathogenesis in Viremic Nonprogressors Is Independent of Gag-Specific Cytotoxic T Lymphocyte Responses.
    Salgado M; Garcia-Minambres A; Dalmau J; Jiménez-Moyano E; Viciana P; Alejos B; Clotet B; Prado JG; Martinez-Picado J
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preservation of Peripheral T Follicular Helper Cell Function in HIV Controllers.
    Buranapraditkun S; Pissani F; Teigler JE; Schultz BT; Alter G; Marovich M; Robb ML; Eller MA; Martin J; Deeks S; Michael NL; Streeck H
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28468877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.